Diabetes Provider Bias to Recommending Diabetes Technology for Patients on Public Insurance in the United States
O. Odugbesan1, A. Mungmode1, N. Rioles1, D. Buckingham2, A. Grant3, R. Hopkins4, K. Cossen5, M. Scott6, P. Mathias7, B. Adams8,…
The T1D Exchange technology equity improvement project: Baseline analysis of insulin pump use
Background: The T1D Exchange Quality Improvement Collaborative (T1DX-QI) is a learning network of 41 US type 1 diabetes clinics. Multiple…
Implication of device disengagement on glycemic control and diabetic ketoacidosis in youth with T1D
Background/Objective: The use of continuous glucose monitors (CGM), insulin pumps (PUMP), and hybrid closed loop systems has been associated with improved…
Insulin Pump Use and Glycemic Control Among Patients with Type 1 Diabetes: Trends from the Largest U.S. Based Multi-Center Observational Study
Background: The use of continuous subcutaneous insulin infusion (CSII), or insulin pump therapy, has been shown to improve glycemic control…
Insulin Pump Use in Patients with Type 1 Diabetes: Real World Data from a Large U.S. Based Multi-Center Observational Study
Background: Insulin pump use is known to improve glycemic control in patients with type 1 diabetes (T1D), however, uptake of…
Increasing Insulin Pump Use across FiveNational Diabetes Centers: Results from the T1D Exchange Quality Improvement Collaborative (T1DX-QI).
The T1DX-QI is a type 1 diabetes learning health system including over 10 diabetes centers across the U.S. The program…
